comparemela.com

Latest Breaking News On - Kura oncology company profile - Page 4 : comparemela.com

StockNews.com Upgrades Kura Oncology (NASDAQ:KURA) to Hold

StockNews.com Upgrades Kura Oncology (NASDAQ:KURA) to Hold
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Canada
United-states
Troy-edward-wilson
Kathleen-ford
Fund-management-co
Kura-oncology-company-profile
Royal-bank
Tower-research-capital
E-fund-management-co
Kura-oncology-inc
Kura-oncology
Get-free-report

Kura Oncology (NASDAQ:KURA) Sees Strong Trading Volume

Kura Oncology (NASDAQ:KURA) Sees Strong Trading Volume
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Troy-edward-wilson
Deerfield-management-companylp-series
Securities-exchange-commission
Blackrock-inc
Affinity-asset-advisors
Nasdaq
Kura-oncology-company-profile
Kura-oncology-inc
Kura-oncology
Get-free-report
Edward-wilson

Kura Oncology, Inc. (NASDAQ:KURA) CEO Troy Edward Wilson Sells 91,052 Shares of Stock

Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) CEO Troy Edward Wilson sold 91,052 shares of Kura Oncology stock in a transaction on Wednesday, January 24th. The stock was sold at an average price of $20.23, for a total value of $1,841,981.96. Following the sale, the chief executive officer now directly owns 559 shares of […]

United-states
Troy-edward-wilson
Securities-exchange-commission
Nasdaq
Deerfield-management-companylp-series
Kura-oncology-company-profile
Affinity-asset-advisors
Kura-oncology-inc
Blackrock-inc
Kura-oncology
Get-free-report
Edward-wilson

Kura Oncology, Inc. (NASDAQ:KURA) Receives $27.17 Average PT from Brokerages

Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the nine brokerages that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 1 year […]

United-states
American
Deutsche-bank
Citigroup-inc
Exchange-traded-concepts
American-century-companies-inc
Vanguard-group-inc
Kura-oncology-company-profile
Kura-oncology-inc
Nasdaq
Kura-oncology

Kura Oncology, Inc. (NASDAQ:KURA) Given Average Rating of "Moderate Buy" by Analysts

Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has earned an average rating of “Moderate Buy” from the nine brokerages that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average twelve-month price objective […]

Metlife-investment-management
Bridgefront-capital
Nasdaq
Cantor-fitzgerald
Kura-oncology-inc
Vanguard-group-inc
Raymond-james-associates
Dimensional-fund-advisors
Kura-oncology-company-profile
Kura-oncology
Get-free-report

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.